Eva Balibrea-Martinez

Badalona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Loss-of-function genetic screen unveils synergistic efficacy of PARG inhibition with combined 5-fluorouracil and irinotecan treatment in colorectal cancer.

Loss-of-function genetic screen unveils synergistic efficacy of PARG inhibition with combined 5-fluorouracil and irinotecan treatment in colorectal cancer.

Journal: Clinical and translational medicine

Published: May 08, 2025

Multikinase Treatment of Glioblastoma: Evaluating the Rationale for Regorafenib.

Multikinase Treatment of Glioblastoma: Evaluating the Rationale for Regorafenib.

Journal: Cancers

Published: December 05, 2024

Microbiome as a predictive biomarker in locally advanced rectal cancer.

Microbiome as a predictive biomarker in locally advanced rectal cancer.

Journal: Microbiome research reports

Published: November 27, 2024

Assessing the Prognostic Value of Cytoplasmic and Stromal Caveolin-1 in Early Triple-Negative Breast Cancer Undergoing Neoadjuvant Chemotherapy.

Assessing the Prognostic Value of Cytoplasmic and Stromal Caveolin-1 in Early Triple-Negative Breast Cancer Undergoing Neoadjuvant Chemotherapy.

Journal: International journal of molecular sciences

Published: September 17, 2024

Chemotactic signaling pathways in prostate cancer: Implications in the tumor microenvironment and as potential therapeutic targets.

Chemotactic signaling pathways in prostate cancer: Implications in the tumor microenvironment and as potential therapeutic targets.

Journal: International review of cell and molecular biology

Published: September 11, 2024

Mitochondrial priming and response to BH3 mimetics in "one-two punch" senogenic-senolytic strategies.

Mitochondrial priming and response to BH3 mimetics in "one-two punch" senogenic-senolytic strategies.

Journal: Cell death discovery

Published: August 12, 2024

Changes In Serum CXCL13 Levels Are Associated With Outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based Treatment.

Changes In Serum CXCL13 Levels Are Associated With Outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based Treatment.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 04, 2024

The European Network for Sinonasal Cancer Research (EUSICA) - A pan-European initiative targeting a group of orphan tumours.

The European Network for Sinonasal Cancer Research (EUSICA) - A pan-European initiative targeting a group of orphan tumours.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 21, 2024

EUSICA/COST IMMUNO-model workshop fostering collaboration to advance sinonasal cancer research: A meeting report.

EUSICA/COST IMMUNO-model workshop fostering collaboration to advance sinonasal cancer research: A meeting report.

Journal: Oral oncology

Published: August 07, 2023

Chromatin factors: Ready to roll as biomarkers in metastatic colorectal cancer?

Chromatin factors: Ready to roll as biomarkers in metastatic colorectal cancer?

Journal: Pharmacological research

Published: April 14, 2023

Curcumin: A Novel Way to Improve Quality of Life for Colorectal Cancer Patients?

Curcumin: A Novel Way to Improve Quality of Life for Colorectal Cancer Patients?

Journal: International journal of molecular sciences

Published: October 17, 2022

Efficacy of CT-P6 (trastuzumab biosimilar) versus reference trastuzumab in combination with pertuzumab in HER2-positive early-stage breast cancer: Preclinical and real-life clinical data.

Efficacy of CT-P6 (trastuzumab biosimilar) versus reference trastuzumab in combination with pertuzumab in HER2-positive early-stage breast cancer: Preclinical and real-life clinical data.

Journal: Breast (Edinburgh, Scotland)

Published: November 17, 2021

Showing 1-12 of 34

Last Updated: 09/26/2026